Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

Clinical trial NCT07318610 · RECRUITING

Trial details

NCT number: NCT07318610
Sponsor: Regeneron Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral Artery Disease (PAD)

Start date: 2026-07-10
Primary completion: 2029-08-18
Enrollment: 7050

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.